The Michigan Hospital Medicine Safety Consortium leads nationwide collaboration to improve antimicrobial use and sepsis care for hospitalized adult medical patients. Through strategic national partnerships with leading healthcare organizations, we advance evidence-based research, implement quality improvements, and share critical findings with the medical community.
These national collaborative relationships create a powerful network that amplifies our impact by combining research excellence, clinical implementation, policy development, and public awareness to drive meaningful improvements in antimicrobial stewardship and sepsis outcomes nationwide.
Strategic National Partnerships for Sepsis Care
We regularly present the findings of our research and large-scale quality improvement at professional society conferences, including the American Thoracic Society, Infectious Disease Week, Society of Critical Care Medicine, and Society of Hospital Medicine. Since 2022, we have partnered with the CDC to develop, publish, and disseminate the CDC’s Hospital Sepsis Program Core Elements, which serve as a “manager’s guide” to establishing and running effective programs to monitor and optimize hospital sepsis care.
In addition to the generous support from our sponsor, Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network (BCN), HMS has partnered with the following national organizations to drive the sepsis initiative:
Centers for Disease Control and Prevention (CDC)
Our partnership with the CDC focuses on developing national standards for sepsis care, conducting surveillance, and disseminating evidence-based protocols to hospitals nationwide through the Core Elements program.
National Institutes of Health (NIH)
Collaboration with the NIH enhances our research capabilities, providing access to cutting-edge methodologies and funding opportunities that advance our understanding of sepsis pathophysiology and treatment approaches.
Sepsis Alliance
Working with Sepsis Alliance allows us to connect our clinical improvements with public awareness campaigns, enhancing recognition of sepsis symptoms among patients and families while supporting survivor communities.
Strategic National Partnerships for Antimicrobial Use
Antibiotic-resistant bacteria are a significant national threat, and their control has become a national priority. Therefore, in addition to our generous support from our sponsor, Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network (BCN), HMS has partnered with the following national organizations to drive this initiative:
Centers for Disease Control and Prevention (CDC)
Our partnership with the CDC focuses on developing national standards for antimicrobial use and disseminating evidence-based protocols to hospitals nationwide through the Core Elements program.
Agency for Healthcare Research and Quality (AHRQ)
AHRQ fosters collaborations to improve patient care, and HMS exemplifies this approach by bringing together hospitals to address quality and safety concerns.
National Quality Forum/Battelle
In collaboration with HMS and with generous support from the Gordon and Betty Moore Foundation, the measures “Inappropriate Diagnosis of UTI in Hospitalized Medical Patients” and “Inappropriate Diagnosis of Community-Acquired Pneumonia (CAP) in Hospitalized Medical Patients” received formal endorsement from NQF (now Battelle) in December 2022.